发明名称 Human multipotent embryonic stem cell-like progenitor cells
摘要 The invention provides a plurality of embryonic stem cell-like progenitor cells, which are isolated from a human tissue by a systemic screening of human mesenchymal stromal stem/progenitor cells and a cell sorting by a cell antigen selected from the group consisting of CD34, CD117, CD133, CD201, GloboH and combination thereof, and cultured in a medium supplemented with at least one or more steroids and one or more growth factors. The cells of the invention express CD34 and exhibit sphere-like clonogenicity in early passages and express multipotent embryonic stem cells (ESCs) like characteristics.
申请公布号 US9234177(B2) 申请公布日期 2016.01.12
申请号 US201113276106 申请日期 2011.10.18
申请人 SUNSHINE LIFE SCIENCE & TECHNOLOGY CORP. 发明人 Tzu-Bi Shih Daniel;Tsai Ming-Song
分类号 C12N5/0775;C12N5/073 主分类号 C12N5/0775
代理机构 Ditthavong & Steiner, P.C. 代理人 Ditthavong & Steiner, P.C.
主权项 1. A method for producing an enriched population of multipotent human CD34+ mesenchymal common progenitor cells (CD34+ MCPCs), further having at least the following characteristics: CD14+, CD117+, CD133+ (AC133+), CD201+, Nestin+, SSEA3+, SSEA4+ and GloboH+, the method comprising: isolating from a human somatic tissue by a systemic screening of human mesenchymal stromal stem/progenitor cells followed by a cell sorting by a cell antigen of CD34, wherein the human somatic tissue is selected from the group consisting of amnion, endometrium and gingival; and culturing in a medium comprising EGF and hydrocortisone or a medium comprising bFGF and EGF.
地址 New Taipei TW